Top Markets
#1 DogBull DogBull +55.75%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +28.67%
#3 DigiByte DigiByte +18.56%
#4 OriginTrail OriginTrail +16.95%
#5 Ethena Staked ENA Ethena Staked ENA +15.58%
#6 Ether.fi Ether.fi +11.05%
#7 Siren Siren +10.95%
#8 MarsCoin MarsCoin +10.44%
#9 龙虾 (Lobster) 龙虾 (Lobster) +9.81%
#10 Purr Purr +9.26%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Shine-On BioMedical Co.,Ltd. Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd.

6926
Rank in Stocks #21821
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and... Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
Share Price
$2.00
Last synced: 2026-08-20
Market Cap
$99.77M
Change (1 day)
-0.47%
Change (1 year)
-15.35%
Country
TW
Trade Shine-On BioMedical Co.,Ltd. (6926)

Category

Healthcare
P/E ratio for Shine-On BioMedical Co.,Ltd. (6926)
P/E ratio as of 2026 TTM: 0
According to Shine-On BioMedical Co.,Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Shine-On BioMedical Co.,Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.